KEVIN BAUTEL: Open Payments
NPI 1598428856 · CLINTON TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 60 payments from 13 companies in 2025. Trend: 2023 $2,022 · 2024 $703 · 2025 $1,879
Food & beverage: $1,879
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $555 |
| E.R. Squibb & Sons, L.L.C. | 12 | $395 |
| Otsuka America Pharmaceutical, Inc. | 5 | $214 |
| Tris Pharma Inc | 7 | $143 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| Corium, LLC | 6 | $88 |
| Supernus Pharmaceuticals, Inc. | 3 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
Products named: COBENFY, LYBALVI, ARISTADA, ABILIFY MAINTENA, Onyda XR, UZEDY, FANAPT, Azstarys.
Industry payments across MI — which companies pay providers there.
